Digital PCR Market Worth US$ 7.9 Billion by 2028 | CAGR of 10.5% | IMARC Group

PRESS RELEASE
Published April 4, 2023

The global digital PCR market size reached US$ 4.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach a value US$ 7.9 Billion by 2028, exhibiting a growth rate (CAGR) of 10.5% during 2023-2028.

Digital polymerase chain reaction, or digital PCR (dPCR), represents an end-point, high-throughput absolute quantitative analytics that aids in measuring the DNA or RNA count of a given sample in a precise and sensitive way. Compared to its traditional counterparts, digital PCR uses a wide range of methods, such as droplet-based, chip-based, and beaming dPCR, to facilitate diverse applications. As a result, digital PCR methods are extensively used in basic and diagnostic research, including human genetic testing, pathogen detection, and forensic sciences.

Get a Free Sample Copy of this Report: https://www.imarcgroup.com/digital-pcr-market/requestsample

Digital PCR Market Trends:

The increasing healthcare expenditure on molecular diagnosis across the globe, on account of the growing prevalence of numerous diseases, including genetic disorders, COVID-19, lung cancer, brain tumors, etc., is among the key elements stimulating the digital PCR market. Moreover, the escalating demand for early diagnosis and treatment has resulted in extensive R&D that focuses on genetic technologies, which is acting as another significant growth-inducing factor.

Besides this, continuous technological advancements in PCR technologies and the development of innovative devices for droplet, chip-based, beam, and crystal dPCR by major market players are positively influencing the global market. Furthermore, the widespread adoption of dPCR devices in reference laboratories for detecting genetic mutations and identifying pathogens is also propelling the market growth. Apart from this, the launch of favorable initiatives undertaken by governmental and federal agencies across the globe, the shifting preferences from plant-derived to genome-based drug discovery, and the rising applications of these devices in food microbiology and veterinary medicine are anticipated to fuel the digital PCR market over the forecasted period.

Checkout Now: https://www.imarcgroup.com/checkout?id=5897&method=1

Digital PCR Market 2023-2028 Competitive Analysis and Segmentation:

Competitive Landscape With Key Players:

The competitive landscape of the digital PCR market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

  • Avance Biosciences Inc.
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • JN Medsys
  • OPTOLANE Technologies Inc.
  • QIAGEN
  • SAGA Diagnostics AB
  • Standard BioTools Inc.
  • Stilla Technologies
    Sysmex Corporation
  • and Thermo Fisher Scientific Inc.

Key Market Segmentation:

The report has segmented the digital PCR market on the basis of product type, technology and application.

Breakup by Product Type:

  • Digital PCR Equipment
  • Consumables and Reagents
  • Software and Services

Breakup by Technology:

  • Droplet Digital PCR
  • BEAMing Digital PCR

Breakup by Application:

  • Clinical Diagnostics
  • Forensics
  • Research
  • Others

Breakup by Region:

  • North America (United States, Canada)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Turkey, South Africa, Others)

Ask Analyst for 10% free customized report: https://www.imarcgroup.com/digital-pcr-market

This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the market in any form.

Key Highlights of the Report:

  • Market Performance (2017-2022)
  • Market Outlook (2023-2028)
  • Market Trends
  • Market Drivers and Success Factors
  • Impact of COVID-19
  • Value Chain Analysis
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Media Contact:
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: sales@imarcgroup.com
Phone: +1-631-791-1145
Address: 30 N Gould St Ste R
City: Sheridan
State: WY
Country: United States
Website:  https://www.imarcgroup.com/

IMARC